CIBRA Capital’s Cidara Therapeutics CDTX Stock Holding History

CIBRA Capital’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,713	Closed	-$4.13M	–	26
2025 Q4	$4.13M	Buy	+18,713	New	+$3.02M	7.1%	7

CIBRA Capital's CDTX Position: Q1 2026 in Review

CIBRA Capital sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 18,713 shares — an estimated $4.13M sold.

CIBRA Capital first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $4.13M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

CIBRA Capital reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
CIBRA Capital sold 18,713 Cidara Therapeutics shares in Q1 2026, an estimated $4.13M.
CIBRA Capital first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
CIBRA Capital's Cidara Therapeutics position peaked at $4.13M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on CIBRA Capital's 13F filing for Q1 2026, filed 24 Apr 2026.